EUCTR2018-000425-31-GB进行中（未招募）1 期
ong term follow-up study of participants following an open label, multicentre, Phase I/II dose escalation trial of a recombinant adeno-associated virus vector (AAV2/5-hRKp.RPGR) for gene therapy of adults and children with X-linked Retinitis Pigmentosa owing to defects in Retinitis Pigmentosa GTPase Regulator (RPGR) - Long term follow-up gene therapy study for X-linked Retinitis Pigmentosa
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Inclusion in the study will be limited to individuals who meet the following criteria:
- •Are able to give informed consent or assent, with or without the guidance of their parent/guardian where appropriate
- •Received AAV2/5-hRKp.RPGR by sub retinal administration in the prior open-label, Phase I/II, dose escalation study (EudraCT 2016-003967-21)
- •Are willing to adhere to the protocol and long-term follow-up
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 18
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 18
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Individuals will be excluded if they are unwilling or unable to meet with the requirements of the study.
研究者
相似试验
进行中（未招募）
1 期
ong term follow-up study of gene therapy trial for LCA2 OPTIRPE65eber Congenital Amaurosis (LCA) caused by mutations in RPE65MedDRA version: 20.0Level: PTClassification code 10070667Term: Leber's congenital amaurosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-000898-20-GBMeiraGTx UK Ltd27
进行中（未招募）
1 期
ong-term follow-up gene therapy study for Achromatopsia (CNGB3)Achromatopsia caused by mutations in the CNGB3 geneMedDRA version: 19.1 Level: LLT Classification code 10000454 Term: Achromatopsia System Organ Class: 100000004850EUCTR2016-003856-59-GBMeiraGTX UK II Ltd27
进行中（未招募）
1 期
ong term follow-up study of gene therapy trial for X-linked Retinitis PigmentosaEUCTR2018-000425-31-Outside-EU/EEAJanssen-Cilag International NV
进行中（未招募）
1 期
ong-term, follow-up study of subjects who completed phase III trials ATX-101-10-16 or ATX-101-10-17 (sodium deoxycholate injection) for the reduction of localized subcutaneous fat in the submental area - Long-term follow-up study of ATX-101 for reduction of localized submental fatReduction of subcutaneous fat in the submental areaMedDRA version: 17.1Level: PTClassification code 10016251Term: Fat tissue increasedSystem Organ Class: 10018065 - General disorders and administration site conditionsEUCTR2011-005026-21-DEKYTHERA Biopharmaceuticals, Inc.201
进行中（未招募）
Unknown
GLAUrious long-term follow-up study of glaucoma laser treatmentGlaucomaEye DiseasesISRCTN96782911BELKIN Vision192